Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

CCCC C4 Therapeutics Inc

5,00

0,10 (2,04%)

Dernière mise à jour : 17:00:38

Retardé de 15 minutes

Biotech Catches Major Premarket Bid

A Massachusetts-based biotech company is stealing the show so far during Tuesday’s premarket hours after it was announced that it has entered into an exclusive license and...

To read the full story on AllPennyStocks.com, click here.

C4 Therapeutics (NASDAQ:CCCC)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024

Plus de graphiques de la Bourse C4 Therapeutics

C4 Therapeutics (NASDAQ:CCCC)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024

Plus de graphiques de la Bourse C4 Therapeutics

Actualités C4 Therapeutics Inc

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mercredi 8 Mai 2024 ( il y a 4 semaines) • Edgar (US Regulatory)

Form 8-K - Current report
Mercredi 8 Mai 2024 ( il y a 4 semaines) • Edgar (US Regulatory)

C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
Mercredi 8 Mai 2024 ( il y a 4 semaines) • GlobeNewswire Inc.

C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Lundi 29 Avril 2024 ( il y a 1 mois) • GlobeNewswire Inc.

C4 Therapeutics to Participate in the Stifel 2024 Targeted Oncology Forum
Mardi 9 Avril 2024 ( il y a 2 mois) • GlobeNewswire Inc.

C4 Therapeutics Presents New Preclinical Data for CFT1946 Highlighting Superior Activity as a Single Agent to Clinically Approved BRAF Inhibitor Standard of Care Combinations at the American Association for Cancer Research Annual Meeting 2024
Lundi 8 Avril 2024 ( il y a 2 mois) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Samedi 9 Mars 2024 ( il y a 3 mois) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samedi 9 Mars 2024 ( il y a 3 mois) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samedi 9 Mars 2024 ( il y a 3 mois) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samedi 9 Mars 2024 ( il y a 3 mois) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samedi 9 Mars 2024 ( il y a 3 mois) • Edgar (US Regulatory)

Form 8-K - Current report
Vendredi 8 Mars 2024 ( il y a 3 mois) • Edgar (US Regulatory)

Plus d'articles sur C4 Therapeutics Inc

NLBNPIT1W726 20240621 26

First Trust Intermediate...

Yunsa Yunlu Sanayi VE Ti... (PK)

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales